Linscomb Wealth’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$307K Buy
+4,273
New +$329K 0.01% 289
2025
Q2
Sell
-3,169
Closed -$215K 306
2025
Q1
$215K Buy
+3,169
New +$190K 0.01% 283
2024
Q4
Sell
-4,754
Closed -$299K 291
2024
Q3
$299K Sell
4,754
-1,002
-17% -$58.5K 0.01% 252
2024
Q2
$340K Sell
5,756
-94,370
-94% -$5.9M 0.02% 235
2024
Q1
$7.99M Sell
100,126
-1,588
-2% -$121K 0.41% 60
2023
Q4
$8.03M Sell
101,714
-4,463
-4% -$318K 0.44% 53
2023
Q3
$7.41M Sell
106,177
-5,040
-5% -$357K 0.43% 56
2023
Q2
$7.69M Sell
111,217
-5,289
-5% -$376K 0.41% 59
2023
Q1
$8.66M Sell
116,506
-2,266
-2% -$190K 0.45% 56
2022
Q4
$11.1M Buy
118,772
+2,152
+2% +$208K 0.56% 38
2022
Q3
$11.1M Buy
116,620
+45
+0% +$4.45K 0.68% 21
2022
Q2
$10.8M Sell
116,575
-2,751
-2% -$268K 0.62% 34
2022
Q1
$12.1M Buy
119,326
+1,701
+1% +$179K 0.58% 34
2021
Q4
$12.1M Buy
117,625
+672
+0.6% +$62.1K 0.58% 40
2021
Q3
$9.93M Buy
116,953
+1,030
+0.9% +$86.3K 0.51% 47
2021
Q2
$9.67M Buy
115,923
+5,145
+5% +$421K 0.5% 50
2021
Q1
$8.33M Buy
110,778
+4,495
+4% +$327K 0.45% 59
2020
Q4
$7.26M Buy
106,283
+3,127
+3% +$203K 0.43% 59
2020
Q3
$6.02M Buy
103,156
+4,246
+4% +$264K 0.41% 62
2020
Q2
$6.43M Buy
98,910
+25,745
+35% +$1.62M 0.47% 55
2020
Q1
$4.34M Buy
73,165
+9,609
+15% +$641K 0.38% 53
2019
Q4
$4.72M Buy
63,556
+170
+0.3% +$11.9K 0.31% 63
2019
Q3
$4M Buy
63,386
+6,379
+11% +$378K 0.32% 63
2019
Q2
$3.11M Buy
57,007
+4,946
+10% +$266K 0.25% 73
2019
Q1
$2.81M Buy
52,061
+2,992
+6% +$185K 0.24% 77
2018
Q4
$3.21M Sell
49,069
-3,610
-7% -$269K 0.3% 59
2018
Q3
$4.15M Buy
52,679
+2,865
+6% +$205K 0.34% 54
2018
Q2
$3.21M Buy
49,814
+3,463
+7% +$228K 0.27% 67
2018
Q1
$2.88M Buy
46,351
+3,249
+8% +$233K 0.25% 70
2017
Q4
$3.13M Buy
43,102
+4,319
+11% +$314K 0.26% 68
2017
Q3
$3.15M Buy
38,783
+2,186
+6% +$173K 0.27% 66
2017
Q2
$2.94M Buy
36,597
+2,732
+8% +$216K 0.26% 69
2017
Q1
$2.66M Buy
33,865
+30,700
+970% +$2.45M 0.24% 71
2016
Q4
$250K Sell
3,165
-172
-5% -$13.9K 0.02% 228
2016
Q3
$297K Sell
3,337
-188
-5% -$17.7K 0.03% 205
2016
Q2
$337K Buy
3,525
+146
+4% +$14.6K 0.03% 194
2016
Q1
$351K Buy
3,379
+570
+20% +$55.4K 0.04% 188
2015
Q4
$275K Buy
+2,809
New +$275K 0.03% 212
2015
Q2
Sell
-2,104
Closed -$217K 272
2015
Q1
$217K Buy
+2,104
New +$213K 0.02% 251

Other funds holding CVS

Linscomb Wealth's CVS Position: Q1 2026 in Review

Linscomb Wealth opened a new position in CVS Health (CVS) in Q1 2026: 4,273 shares worth $307K. The stake represents 0.01% of the portfolio and ranks #289 among its holdings. This is a return to the name: Linscomb Wealth previously reported a position in CVS as recently as Q1 2025.

Linscomb Wealth first reported a position in CVS in Q1 2015 and has held it in 39 quarters since. The position peaked at $12.1M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Linscomb Wealth held 4,273 shares of CVS Health worth $307K as of Q1 2026.
  • CVS Health was a new Linscomb Wealth position in Q1 2026.
  • CVS Health made up 0.01% of Linscomb Wealth's portfolio in Q1 2026, its #289 holding.
  • Linscomb Wealth first reported a position in CVS Health in Q1 2015 and has held it in 39 quarters since.
  • Linscomb Wealth's CVS Health position peaked at $12.1M in Q4 2021.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Linscomb Wealth's 13F filing for Q1 2026, filed 11 May 2026.